Effects of clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man.
D001646:Bile / Q000032:analysis; D001647:Bile Acids and Salts / Q000032:analysis; D002250:Carbon Radioisotopes; D002763:Cholecystectomy; D002765:Cholecystography; D002769:Cholelithiasis / Q000139:chemically induced; D002784:Cholesterol / Q000009:adverse effects / Q000032:analysis / Q000097:blood; D002793:Cholic Acids / Q000096:biosynthesis / Q000378:metabolism*; D002994:Clofibrate / Q000494:pharmacology*; D003276:Contraceptives, Oral / Q000009:adverse effects; D004338:Drug Combinations; D004967:Estrogens / Q000494:pharmacology*; D005215:Fasting; D005243:Feces / Q000032:analysis; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000601:surgery; D007700:Kinetics; D050356:Lipid Metabolism; D008055:Lipids / Q000032:analysis; D008074:Lipoproteins / Q000097:blood; D008102:Liver Circulation; D008297:Male; D008525:Medroxyprogesterone / Q000494:pharmacology; D010743:Phospholipids / Q000032:analysis; D011374:Progesterone / Q000494:pharmacology*; D014280:Triglycerides / Q000097:blood
D001647:Bile Acids and Salts; D002250:Carbon Radioisotopes; D002793:Cholic Acids; D003276:Contraceptives, Oral; D004338:Drug Combinations; D004967:Estrogens; D008055:Lipids; D008074:Lipoproteins; D010743:Phospholipids; D014280:Triglycerides; D011374:Progesterone; D002784:Cholesterol; D002994:Clofibrate; D008525:Medroxyprogesterone